KindlyMD, Inc. (NASDAQ:NAKA) Given Consensus Recommendation of “Hold” by Brokerages

KindlyMD, Inc. (NASDAQ:NAKA) has been given an average rating of “Hold” by the five research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $22.3333.

A number of equities analysts recently weighed in on NAKA shares. Weiss Ratings reissued a “sell (d-)” rating on shares of KindlyMD in a research note on Friday, August 7th. TD Cowen lifted their price objective on KindlyMD from $1.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Finally, Wall Street Zen raised KindlyMD to a “sell” rating in a research note on Saturday, May 23rd.

Insider Transactions at KindlyMD

In related news, CEO David F. Bailey purchased 104,833 shares of KindlyMD stock in a transaction on Wednesday, May 27th. The stock was acquired at an average cost of $4.84 per share, for a total transaction of $507,391.72. Following the completion of the acquisition, the chief executive officer owned 3,120,361 shares of the company’s stock, valued at $15,102,547.24. This trade represents a 3.48% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have acquired 191,448 shares of company stock worth $992,908 over the last 90 days. 24.49% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in NAKA. SG Americas Securities LLC acquired a new position in shares of KindlyMD during the fourth quarter worth approximately $61,000. Virtu Financial LLC bought a new position in shares of KindlyMD in the fourth quarter valued at $151,000. J. Derek Lewis & Associates Inc. bought a new position in KindlyMD in the 4th quarter valued at about $167,000. Truist Financial Corp acquired a new position in KindlyMD during the 4th quarter valued at about $176,000. Finally, Waddell & Associates LLC purchased a new position in shares of KindlyMD during the fourth quarter valued at approximately $201,000.

KindlyMD Stock Performance

Shares of NASDAQ NAKA opened at $5.03 on Thursday. KindlyMD has a 52-week low of $3.33 and a 52-week high of $528.00. The firm has a 50 day moving average price of $4.39 and a two-hundred day moving average price of $7.43. The stock has a market cap of $90.04 million, a P/E ratio of -0.14 and a beta of 15.94.

KindlyMD (NASDAQ:NAKA) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($6.65) EPS for the quarter. KindlyMD had a negative return on equity of 63.45% and a negative net margin of 1,067.93%.The business had revenue of $35.87 million for the quarter. Analysts predict that KindlyMD will post -16.8 earnings per share for the current fiscal year.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.